Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WORLD VIEW BLOG: Austerity-driven off-label prescribing must stop

This article was originally published in Scrip

Executive Summary

It is worrying to observe how countries in Europe are increasingly challenging harmonized EU rules on authorizing drugs for the sake of cutting costs in their national health systems. It seems that in particular, off-label prescribing is now seen as a good way to make savings in healthcare spending. This hasn't always been the case. Off-label prescribing was largely limited to cases where no authorized treatment existed. In times of austerity, however, this has clearly changed.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts